Rutgers University
Rutgers University

Rutgers Cancer Institute of New Jersey

Cancer Institute of New Jersey

August 10, 2016
Michele Fisher

Research from investigators at Rutgers Cancer Institute of New Jersey and Princeton University has identified a new approach to cancer therapy in cutting off a cancer cell’s ‘fuel supply’ by targeting a cellular survival mechanism known as autophagy. Rutgers Cancer Institute Deputy Director Eileen P. White, PhD, distinguished professor of molecular biology and biochemistry in the School of Arts and Sciences at Rutgers, The State University of New Jersey, and Rutgers Cancer Institute researcher ‘Jessie’ Yanxiang Guo, PhD, assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, are the co-corresponding authors of the work published in the August 10 edition of Genes & Development. They share more about the research, which focused on lung cancers driven by the Kras protein:

Q: Why is this topic important to explore?

A: Between 85 to 90 percent…

View original post 765 more words